Gyre Therapeutics Inc (GYRE)
9.79
-0.40
(-3.88%)
USD |
NASDAQ |
May 29, 16:00
9.95
+0.16
(+1.63%)
After-Hours: 20:00
Gyre Therapeutics Total Liabilities (Quarterly): 33.24M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 33.24M |
| Date | Value |
|---|---|
| March 31, 2023 | 13.88M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
13.88M
Minimum
Mar 2023
33.24M
Maximum
Mar 2024
23.56M
Average
23.56M
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 11.36M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Protalix BioTherapeutics Inc | 60.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 122.01M |
| Shareholders Equity (Quarterly) | 56.64M |
| Current Ratio | 3.219 |